Detalhe da pesquisa
1.
A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.
N Engl J Med
; 370(19): 1809-19, 2014 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-24678979
2.
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia.
Am J Cardiol
; 89(6): 672-8, 2002 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-11897208